Sat.Sep 07, 2019 - Fri.Sep 13, 2019

article thumbnail

Not Your Typical MSL

The Nontraditional Pharmacist

Dr. Qureshi expands our understanding of the typical Medical Science Liaison role by taking a look at his position in managed markets. Great feature for those considering industry as a career option! Name: Nabeel Qureshi. Title: Medical Liaison, Managed Markets. Interview Summary. Matt [00:00:00] Matt Paterini here with The Nontraditional Pharmacist, part of the Pharmacy Podcast Network.

article thumbnail

Launch excellence in a disrupted world – challenges & opportunities

pharmaphorum

Overview The launch environment has undergone huge changes as the pharmaceutical industry’s focus has moved from primary care to specialty launch, but its future will be transformed even more radically. The advent of highly novel cell and gene therapies as well as prescription digital therapeutics is providing a serious set of forces for change in the market.

40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Hydrochlorothiazide, an Unexpected Drug of Abuse

Med Ed 101

I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found to have hydrochlorothiazide in his system. In clinical practice, for medical […].

40
article thumbnail

Methotrexate and Thrombocytopenia Case

Med Ed 101

The following case on methotrexate and thrombocytopenia was donated by Kirk Seale, M.S., PharmD, BCGP. Kirk received his Master’s degree in Drug regulatory affairs from the University of Florida and received his PharmD from the University of Mississippi. He has also been appointed to serve on the Government Affairs Committee with The American Society of Consultant […].

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.